News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Polydex Pharmaceuticals Provides Third Quarter Report With Continued Improvement In Sales And Profit
December 14, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TORONTO -- (MARKET WIRE) -- December 14, 2006 -- Polydex Pharmaceuticals Limited (NASDAQ: POLXF) reports financial results for its third fiscal quarter, the three-month period ended October 31, 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Startups
Addition Debuts With $100M to Advance One-Time Therapies for Rare, Chronic Diseases
December 17, 2025
·
1 min read
·
Tristan Manalac
Vaccines
Pfizer CEO Blasts HHS’ Anti-Vaccine Policies as Revenue Outlook Dims
December 16, 2025
·
3 min read
·
Annalee Armstrong
Venture capital
Ambros Launches With $125M To Bring Italian Non-Opioid Pain Drug to America
December 16, 2025
·
1 min read
·
Annalee Armstrong
Autoimmune disease
Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership
December 15, 2025
·
1 min read
·
Annalee Armstrong
